EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase III)Open Access · CC BY 4.0

Long‐term effectiveness of a novel intra‐oral electro‐stimulator for the treatment of dry mouth in patients with Sjogren's syndrome: A randomised sham‐controlled feasibility study ( LEONIDAS ‐1)

Stefano Fedele iD, Arwa Al-Hamad, Valeria Mercadante iD, Stephen Porter, David Isenberg, Ana Poveda-Gallego, Sarah T Brown

Journal of Oral Pathology & Medicine · 2023

DOI: 10.1111/jop.13452 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Oral Pathology & Medicine, 2023. Verfasst von Stefano Fedele und 6 weiteren Autor:innen. Beteiligte Einrichtung: UCL Eastman Dental Institute, University College London, London, UK. Hauptthemen laut MEDLINE: Sjogren's Syndrome, Xerostomia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Versus Arthritis, Arthritis Research UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Effective treatments for dry mouth of Sjogren's syndrome are limited and hampered by adverse effects. The aim of LEONIDAS‐1 was to explore the feasibility of salivary electrostimulation in individuals with primary Sjogren's syndrome, as well as parameters required to inform the design of a future phase III trial.

Methods

Multicentre, parallel‐group, double‐blind, randomised sham‐controlled trial in two UK centres. Participants were randomised (1:1, computer‐generated) to active or sham electrostimulation. The feasibility outcomes included screening/eligibility ratio, consent, and recruitment and drop‐out rates. Preliminary efficacy outcome included dry mouth visual analogue scale, Xerostomia Inventory, the EULAR Sjögren's syndrome patient reported index‐Q1, and unstimulated sialometry.

Results

Forty‐two individuals were screened, of whom 30 (71.4%) met the eligibility criteria. All eligible individuals consented to recruitment. Out of the 30 randomised participants (active n = 15, sham n = 15), 4 dropped out and 26 (13 vs. 13) completed all study visits as per protocol. Recruitment rate was 2.73 participants/month. At 6‐month post‐randomisation the difference in mean reduction in visual analogue scale, xerostomia inventory and EULAR Sjögren's syndrome patient reported index‐Q1 scores between groups were 0.36 (95% CI: −0.84, 1.56), 3.31 (0.43, 6.18), and 0.23 (−1.17, 1.63), respectively; unstimulated salivary flow increased by a mean of 0.98 mL/15 min, all in favour of the active group. No adverse events were reported.

Conclusion

LEONIDAS‐1 results support progression to a phase III definitive randomised controlled trial of salivary electrostimulation in individuals with Sjogren's syndrome. Xerostomia inventory could be considered the primary patient‐centred outcome measure and the corresponding observed treatment effect could inform the sample size of a future trial.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sjogren's SyndromeXerostomiaHumansFeasibility StudiesTreatment OutcomeDouble-Blind Method

Stichwörter der Autor:innen

salivary glandswhole unstimulated salivary flow rate

Autor:innen und Institutionen

  • UCL Eastman Dental Institute, University College London, London, UK.
  • NIHR UCLH Biomedical Research Centre, London, UK.
  • King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, Saudi Arabia.
  • College of Dentistry, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Centre for Rheumatology, Division of Medicine, University College London, London, UK.
  • Oral Medicine, Birmingham Dental Hospital and School of Dentistry, Birmingham, UK.

ORCID-Profile: Stefano Fedele, Valeria Mercadante

Förderung

  • Versus Arthritis
  • Arthritis Research UK

Zitieren

APA

Fedele, S., Al-Hamad, A., Mercadante, V., Porter, S., Isenberg, D., Poveda-Gallego, A., & Brown, S. T. (2023). Long‐term effectiveness of a novel intra‐oral electro‐stimulator for the treatment of dry mouth in patients with Sjogren's syndrome: A randomised sham‐controlled feasibility study ( LEONIDAS ‐1). Journal of Oral Pathology & Medicine. https://doi.org/10.1111/jop.13452

Vancouver

Fedele S, Al-Hamad A, Mercadante V, Porter S, Isenberg D, Poveda-Gallego A, et al. Long‐term effectiveness of a novel intra‐oral electro‐stimulator for the treatment of dry mouth in patients with Sjogren's syndrome: A randomised sham‐controlled feasibility study ( LEONIDAS ‐1). Journal of Oral Pathology & Medicine. 2023. doi:10.1111/jop.13452

BibTeX
@article{Fedele2023,
  author = {Fedele, Stefano and Al-Hamad, Arwa and Mercadante, Valeria and Porter, Stephen and Isenberg, David and Poveda-Gallego, Ana and Brown, Sarah T},
  title = {Long‐term effectiveness of a novel intra‐oral electro‐stimulator for the treatment of dry mouth in patients with Sjogren's syndrome: A randomised sham‐controlled feasibility study ( LEONIDAS ‐1)},
  journal = {Journal of Oral Pathology & Medicine},
  year = {2023},
  doi = {10.1111/jop.13452}
}
Kostenlos starten →